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Summary: An improved method for the simultaneous gas-chromatographic determination of individual 17-oxosteroids
and of pregnanediol in the same sample of urine is described. The method involves the following steps. The urinary
sample is chromatographed on Amberlite XAD-2. The fraction containing the steroid conjugates is evaporated; the
residue is dissolved in -heptane and the organic phase extracted with water. The steroid glucuronides are hydrolysed
by a bacterial ß-glucuronidase; subsequently, the steroid sulphates are solvolysed in ethyl acetate. Free 17-oxosteroids
and pregnanediol are separated by two-dimensional thin-layer chromatography. The zone containing the steroids to be
investigated is eluted; after evaporation, the residue is treated with N-methyl N-trimethyl silyl trifluoroacetamide. The
reaction mixture is injected into a gas Chromatograph; the trimethyl silyl ethers of the individual 17-oxosteroids and
of pregnanediol are quantitated by measuring the peak heights.
The losses occurring during the working-up procedure are corrected for by measuring the recovery of radioactive dehy-
droepiandrosterone which is added as glucuronide and as sulphate to the urinary sample. The specificity of the method
was established by mass fragmentography.
Eine verbesserte Methode zur gleichzeitigen Bestimmung verschiedener 17-Oxosteroide und von Pregnandiol im Urin
mit Hilfe der Gaschromatographie
Zusammenfassung: Es wird eine verbesserte Methode zur gleichzeitigen Bestimmung verschiedener 17-Oxosteroide und
von Pregnandiol in derselben Urinprobe mit Hilfe der Gaschromatographie angegeben. Das Verfahren umfaßt folgende
Analysen- und Reaktionsschritte. Die Urinprobe wird an Amberlite XAD-2 chromatographiert. Die Fraktion, welche
die Steroidkonjugate enthält, wird eingedampft und der Rückstand in rc-Heptan aufgenommen. Die Steroidkonjugate
werden mit Wässer aus der organischen Phase extrahiert. Anschließend werden die Steroidglucuronide mit einer bak-
teriellen ß-Glucurdnidase hydrolysiert und die Steroidsulfate in Essigsäureethylester solvolysiert. Die freien 17-Oxo-
steroide und Pregnandiol werden durch Dünnschichtchromatographie von begleitenden Verunreinigungen befreit. Die
steroidhaltende Zone des Dünnschichtchromatogramms wird eluiert und der Rückstand des Eluats mit N-Methyl-N-tri-
methylsilyl-trifluoracetamid behandelt. Ein aliquoter Teil der Reaktionsmischung wird in den Gaschromatographen in-
jiziert; die quantitative Bestimmung der Trimethylsilyläther der verschiedenen 17-Oxosteroide und von Pregnandiol
erfolgt durch Ausmessung der aufgezeichneten Peakhöhen.
Die Korrektur von Aufarbeitungsverlusten erfolgt durch Ermittlung der Wiederfindung von radioaktivem Dehydro-
epiandrosteron, das als Glucuronid und Sulfat der Urinprobe zugesetzt wird. Die Spezifität der hier beschriebenen
Methode wurde mit Hilfe der Massenfragmentographie überprüft und bestätigt.
Introduction the procedure as modified by Norymberski et al. (1) in
1953 has been the most popular one. However, in certain
The determination of 17-oxosteroids in urine has been clinical conditions, such as adreno-genital syndrome,
in widespread use for more than three decades. Of the carcinoma of the adrenal cortex and gonadal disorders,
numerous methods which have been recommended for it is desirable to obtain information about the urinary
the measurement of the so-called total 17-oxosteroids, excretion of individual 17-oxosteroids. Moreover, it
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seems not unreasonable to assume that, in a number of
endocrinological disorders, the determination of indi-
vidual 17-oxosteroids may contribute to a better under-
standing of the underlying pathobiochemical processes.
The first method for the fractionation of 17-oxosteroids
was published by Dingemanse and her colleagues (2, 3)
and later improved by Kellie & Wade (4); the indiviual
17-oxosteroids were separated from each other by chro-
matography on alumina. These time-consuming methods
were succeeded by procedures involving gas chromato-
graphy (5, 6, 7). A critical evaluation of the column
chromatography procedures and also of the gas Chroma-
tographie methods makes it likely that, in many instances,
results obtained do not reflect the correct values for the
individual 17-oxosteroids. This is due mainly to two
reasons: (1) Hydrolysis of steroid conjugates whether
by hot mineral acids or by enzymes, in a native urine
sample without prepurification, leads to artifacts or/and
incomplete cleavage £8—11). (2) Insufficient purification
of the sample prior to gas chromatography may give rise
to false results.
The present method has been developed with the aim of
avoiding the formation of artifacts by carrying out
hydrolysis of the steroid conjugates in prepurified urine.
Moreover, a special thin-layer Chromatographie technique
was devised which yields highly purified samples suitable
for the quantitative and specific determination by gas
chromatography. The high accuracy of the method is
ascertained by using radioactive steroid conjugates as
internal standards.
Chemicals
Propane-l,2-diol, ethyl acetate, w-heptane, toluene, benzene,
cyclohexane, chloroform, ethanol and methanol were of
A. R. grade. Ethyl acetate, chloroform and methanol were
distilled before use. Disodium hydrogen or t ho phosphate,
potassium dihydrogen orthophosphate, sodium hydrogen
carbonate, sodium hydroxide, sodium chloride, sulphuric
acid were of A. R. grade. Bacterial 0-glucuronidase, type 1
from/f. co/i, was obtained from Sigma, St. Louis, Mo.,
U.S.A.
The following antibiotics were used: Streptomycin sulphate
(Bayer, Leverkusen, F. R. G.): 1.25 g is dissolved in 1.3 ml
distilled sterile water (final concentration 500 g/1 strepto-
mycin). Nebacetin dry powder (Byk^Gulden, Konstanz, F. R. G.):
An amount, corresponding to 50 mg neomycin sulphate and
2500 U Bacitracin, is dissolved in 1.0 ml of 9 g/1 sodium chloride
solution. Penicillin G (HormonrChemie, M nchen, F. R. G.):
ΙΟ6U (l M ) is dissolved in 2.5 ml distilled sterile water.
Phosphate buffer (0.45 mol/1; pH 7.0) was prepared by dis-
solving 61.24 g potassium dihydrogen orthophosphate in
1000 ml distilled water and 80.12 g disodium hydrogen ortho-
phosphate dihydrate in 1000 ml distilled water. 41.3 ml of
the potassium salt solution was mixed with 58.7 ml of the
sodium salt solution to give 100 ml of phosphate buffer (0.45
mol/1; pH 7.0). Phosphate buffer (O.Q75 mol/1; pH 7.0) was
prepared by diluting 1 ml of the phosphate buffer (0.45 riiol/1)
with 5 ml distilled water.
Glassware
Conical flasks with NS 14.5 standard ground-glass joint
(50 ml capacity). Kober test tubes with NS 14.5 standard
ground-glass joint (40 ml capacity). Conical test tubes with
NS 14.5 standard ground-glass joint (capacity 10 ml). Mikro-
caps (capacity 10 μΐ) (Drummonds Scientific, Broomall,
Pa., U.S.A.). Micro syringes (100 μΐ) (ESGE, c/o W. G nther,
Analysentechnik, D sseldorf, F. R. G.). Counting vials
(W. Zinsser, Frankfurt/Main, F. R. G.) for liquid scintillation
measurements. Assorted pipettes of different capacity, Pasteur
pipettes, and capillary pipettes (for thin-layer chromatography).
Materials and Equipment
Steroids
Pregnanediol (50-pregnane-3a, 20a-diol), aldosterone (18,11-
hemiacetal of 110, 21-dihydroxy-3, 20-dioxo-4-pregnen-18-ai),
androsterone (3a-hydroxy-5/3-androstan-l 7-one), etiocholanolone
(3a-hydroxy-5a-androstan-l 7-one), dehydroepiandrosterone
(30-hydroxy-5-androsten-17-one), 11-oxoandrosterone (3α-
hydroxy-5a-androstane-ll, 17-dione),. 11-oxoetiocholanolone
(3a-hydroxy-50-androstane-ll, 17-dione), 110-hydroxy-
androsterone (3α, 110-dihydroxy-5a-androstan-l7-one) and
110-hydroxy-etiocholanolone (3α, ll/3-dihydroxy-50-androstan-
17-one) were obtained from Ikapharm, Ramat-Gan, Israel. The
purity of steroids was checked by thin-layer and gas liquid
chromatography. Stock solutions (final concentration lg/1)
were prepared by dissolving steroids in benzene/ethanol
(volumes, 90 ml + 10 ml). The solutions are stable for 6 months
when kept at + 4 °C.
Radioactive standards
(7o-3H]dehydroepiandrosterone 0-/)-glucuronide, specific
activity 20 Ci/mmol (New England Nuclear, Boston, Mass.,
U.S.A.), f4-14C]dehydroepiandrosterone sulphate (ammonium
salt), specific activity 59.4 mCi/mmol (New England Nuclear,
Boston, Mass., U.S.A.) and [7a-3H]dehydroepiandrosterone
sulphate (potassium salt), specific activity 290 mCi/mmol
(Radiochemical Centre Amerstiam, Bucks. U. K., c/o Buchler,
Braunschweig, F. R. G.) were used as internal standards. The
purity of steroids was checked by thin-layer chromatography,
using a radiochromatogram scanner (BF-Vertriebs-GmbH fur
Me technik, Karlsruhe, F. R. G.).
Accessories
Water bath, centrifuge, shaker, rotavapor, tanks for thin-layer
chromatography, UV-lamp.
Column chromatography
Amberlite XAD-2, coarse, 0.5-1.00 mm diameter (Serva*
Entwicklungslabor, Heidelberg, F. R. G.) was first washed
with water (five times with the threefold volume of the resin)
to remove the fines and then washed with methanol (twice with
the twofold volume of the resin) to remove impurities. The
purified resin was kept under water at room temperature before
use. The columns (20 X 1.0 cm internal diameter) were fitted
at the bottom with a G-l sintered glass filter and a capillary
outlet. At filling time, the capillary exit was closed by means of
a PTFA stop cock and the aqueous suspension of Amberlite (5 g)
poured slowly into the column. The resin was allowed to settle
under gravity. The upper end of the filled column was covered
with glass wool and glass beads (3 mm diameter). After use,
the resin was discarded.
Thin-layer chromatography
Aluminium sheets (sizes 20 X 20 cm), coated with silica gel
F2S4 (thickness of the layer 0.25 mm) (Merck, Darmstadt,
F. R. G.) were prewashed for 24 h with chloroform/methanol
volumes, 93 ml + 7 ml), using the technique described by fritter
(12).
(fas liquid chromatography
Any gas Chromatograph with a flame ionisation detector may be
used (e. g. Philips-Pye, Philips Elektronik Industrie GmbH, Ham-
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burg, F. R. G.). It contains a siliconised glass column (2.7 m
X 2.4 mm internal diameter), packed with a mixture of 1 part
3%OV-210 and 1.8 part 3% OV-225 on Chromosorb WHP 100
-120 mesh (Supelco, Bellefonte, Pa., U.S.A., c/o Packard Instru-
ments, Frankfurt/Main, F. R. G.)· Column temperature: 235 °C.
Inlet temperature: 250 °C. Detector temperature: 275 °C. Purged
nitrogen was used as carrier gas at a flow rate of 35 ml/min; the
flow of hydrogen (50 ml/min) and air (250 ml/min) were adjusted
for maximal sensitivity.
N-methyl N-trimethyl silyl trifluoracetamide (MSTFA) (Macherey
and Nagel, D ren, F. R. G.) was used as silylating agent.
Liquid scintillation counting
Any liquid scintillation spectrometer (e. g. Packard) may be used.
The scintillation fluid contained 4 g of 2,5-diphenyl-oxazol (PPO)
in 1 1 of dry sulphur-free toluene (Packard Instruments, Frankfurt/
Main, F. R. G.).
Procedure
Collection and storage of urine samples
After urine has been collected over a period of 24 h, its volume is
measured and then made up with water to 1200 ml or, if more
has been excreted, to a larger multiple of 100 ml. The diluted
urine can be kept indefinitely at — 10 °C without any detectable
change in its concentrations of 17-oxosteroids and pregnanediol.
Chromatography on XAD-2
10 ml of urine is used for analysis. The pH is adjusted to 7.0
with 2 mol/1 sodium hydroxide and 0.45 mol/1 phosphate buffer;
to each sample, 3,7 kBq (100 nCi) [7o-3Hldehydroepiandro-
sterone glucuronide and 1,85 kBq (50 nCi) [4-14C]dehydroepi-
androsterone sulphate are added as internal standards. Chromato-
graphy is carried out according to Bradlow (13) in the following
way:
(a) neutralised urinary sample,
(b) 40 ml water,
(c) 20 ml methanoL
The last fraction contains the conjugates of 17-oxosteroids and
pregnanediol, and is collected in conical flasks; after addition of
2 drops of propanediol, the methanol and traces of water are
evaporated under vacuum. The residue remains dissolved in pro-
panediol.
Extraction of steroid conjugates
S ml w-heptane is added to the propanediol solution; the steroid
conjugates are then extracted with water ( 1 X 3 ml, 2 X 1 ml).
Enzymatic hydrolysis
To the combined aqueous extracts, the followiiig additions are
made: 1 ml of 0.45 mol/1 phosphate buffer, 2500 U 0-glucuronid-
ase, dissolved in 1 ml of 0.075 mol/1 phosphate buffer, 2.5 μ\
of the penicillin G solution, 10 μΐ of the Nebacetin solution,
7 μΐ of the streptomycin solution and 2 dfpps of chloroform.
The mixture is incubated for 24 h at 37 °C in a water bath.
The free steroids are extracted with ethyl acetate (1 X 10 ml).
The extract is transferred to a Kober test tube and the organic
phase evaporated under vacuum (Fraction Ej).
Solvolysis
Solvolysis is carried out according to Burstein & Liebermann (14).
The remaining aqueous phase is adjusted to pH l by the addition
of 1 mol/1 sulphuric acid; 1.4 g sodium chloride is added arid
dissolved by shaking. The mixture is then extracted with ethyl
acetate (3 X 5 ml). The extracts are combined by transferring
then! separately to the Kober test tube containing fraction EI .
This solution is incubated for 24 h at 37 °C in a water bath. At
the end of the solvolysis, the ethyl acetate phase is washed with
sodium hydrogen carbonate solution (1x1 ml). The aqueous
solutions are discarded, and the organic phase is evaporated under
vacuum.
Thin-layer chromatography
The residue, containing the liberated steroids from the glucuronide
and sulphate fractions, is dissolved in a small volume of chloroform/
methanol (volumes, 90 ml + 10 ml); the solution is applied to the
plate as a 2 cm-line. For the localization of the 17-oxosteroids and
pregnanediol, reference steroids with a low Rp-value (11-oxoeti-
ocholanolone) and with a high Rp-value (androsterone) are also
applied. The chromatogram is developed with cyclohexane/
ethyl acetate/methanol (volumes, 10 ml + 90 ml + 5 ml).
The lane with the reference steroids is cut off and sprayed with
sulphuric acid; the steroids are made visible by heating the strips
at 120 °C for 5 min. After localization of the steroid-containing
zone, the thin-layer plate is turned around 90°; since aldosterone
has a low Rp-value, as compared with the 17-oxosteroids, and is
easily visible under the UV-lamp, it is used as reference steroid
for the following thin-layer chromatography steps and applied
as a vertical 2 cm-line at a distance of 2 cm. The thin-layer
chromatogram (aluminium sheet) is put between two glass plates
which are in a horizontal position and cover a glass jar, containing
chloroform/methanol (volumes, 93 ml + 7 ml) (15). About 4/5th
of the thin-layer sheet are above the two glass plates and exposed
to air. The solvent mixture evaporates as soon as it passes the glass
plates. By using this technique, the 17-oxosteroids and pregnan-
ediol fraction as well as aldosterone are concentrated and yield
distinct small spots with a diameter less than 1 mm within 15 min
of development.
The position of aldosterone is checked under UV light. Following
this step, the thin-layer chromatogram is developed with chloro-
form/methanol (volumes, 93 ml + 7 ml) on the usual way. After
the solvent has reached a distance of 8 cm from the starting line,
the zone containing the 17-oxosteroids and pregnanediol is
localised by comparison with authentic androsterone and pregnan-
ediol, using sulphuric acid for visulization. The thin-layer plate
is again turned around 90° and the steroid-containing zone con-
centrated by developing the chromatogram with chloroform/
methanol (volumes, 93 ml + 7 ml) in the same way as described
above.
The small area containing the 17-oxosteroids and pregnanediol
is cut off and put into a glass tube with a sealed-in sintered glass
support (G-4) at the bottom. Elution is carried out with 3 ml of
chloroform/methanol (volumes, 93 ml + 7 ml); the eluate is
collected into a conical glass tube and evaporated under vacuum.
Measurement of radioactivity
The residue is taken up in 100 μΐ benzene/ethanol (volumes,
90 ml + 10 ml). For the determination of recovery, 10 μΐ of
the solution is pipetted with a "mikrocap" into a counting
vial, containing 10 ml of scintillation fluid.
Gas liquid chromatography
The remaining solution (90 μΐ) is evaporated under vacuum.
The residue is treated with 90 μΐ MSTFA for 60 min at 60 °C
in the conical glass tube which is stoppered. For the gas
Chromatographie determination, 2 μΐ of the MSTFA solution
is injected into the column.
Calculation of the results
The amounts of 17-oxosteroids and pregnanediol are calculated
from the gas Chromatographie tracings by measuring the peak
heights. The excretion of the individual 17-oxosteroids and
pregnanediol is calculated according to the following formula
Steroid (μηιοΙ/24 h) = m X VX f
where:
m = amount of steroid in pmol as determined by gas liquid
chromatography
V = volume of the 24 h-urine in ml
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f = conversion factor; 5 Χ 10"4, if the volume of the urinary
sample is 10 ml and that of the sample injected into the
gas Chromatographie column is 2 μΐ
R = % recovery as determined from measurement of radioactivity
of the internal standard.
Calibration
Reference steroids are treated in the same way as the sample
to be investigated. Regression lines are calculated on the basis
of measurements of three different amounts of each individual
steroid. The amounts of steroids, present in the sample qu nti-
tated by gas liquid chromatography (m), are calculated by means
of the regression lines.
Tab. 2. Precision of the method calculated from 7 determina-
tions in 4 days (4 series).
Steroid Mean value S. D. Coeffi-
[μπκ>1/24η] (μηιοΙ/24 h] cient of
variation
Pregnanediol 0.33
Androsterone 1.90
Etiocholanolone 1.03
Dehydroepiandrosterpne 1.10
1 1 -Oxoandrpsterone 0.67
11-Oxoetiocholanolone 0.89
ll/MIydroxyandrosterone 1.04
110-Hydroxyetiocholanolone 1.02
0.03
0.18
0.12
0.06
0.10
0.05
0.09
0.07
10.3
9.4
11.6
5.7
15.5
5.7
9.0
7.3
Results
Criteria of reliability
Precision
The precision of the method within the series was deter-
mined for each steroid at various concentrations in three-
fold to sixfold estimations. The standard deviations
(S. D.) and coefficient of variation (CV) at the different
concentration levels are given in table 1. The precision
from day to day (tab. 2) was calculated from seven
determinations of the same urinary sample in four
days (4 series).
Accuracy
Using radioactive dehydroepiandrosterone glucuronide
and dehydroepiandrosterone sulphate as internal
standards, all values are corrected for 100% recovery.
These recoveries exclude possible, although practically
negligible losses occurring during gas chromatography.
The recovery of radioactivity was 94.9 ± 5.9% (n = 5),
when [7a-3H]dehydroepiandrosterone glucuronide was
added to the urine sample, 94.8 ± 5.7% (n = 4) when
[4-14C]dehydroepiandrosterone sulphate was added, and
95.0 ± 2.6 (n = 37) when [7a-3H]dehydroepiandrosterone
sulphate was added.
Specificity
The specificity of the method has been investigated by
combined gas chromatography-mass spectrometry and
by mass fragmentography. The mass spectra, taken from
the derivatives of the urinary steroids, were identical
with those of the derivatives of the reference standards.
The values, measured by mass fragmentography, agreed
well with those obtained by gas liquid chromatography.
For further details, see (16,17).
Tab. 1. Precision of the method at two concentration ranges
and coefficients of variation for the individual steroids.
Steroid Range n
[/xmol/24 h]
Pregnanediol 1.13- 1.57 13
1.58- 3.91 19
Androsterone 2.62- 5.17 7
5.18-14.14 25
Etiocholanolone 2.83- 5.17 12
5.18-19.10 21
Dehydroepi- 0.63- 5.21 16
androsterone 5.22- 7.92 11
11-Oxo- 0.82- 1.64 7
androsterone 1.65- 3.52 12
11-Oxo- 0.66- 1.64 12
etiocholanolone 1.65- 2.99 10
110-Hydroxy- 1.21- 1.63 5
androsterone 1.64- 3.56 28
110-Hydroxy- 1.01- 1.63 7
etiocholanolone 1.64- 3.56 17
S.D.
[μπιοΙ/24 hl
0.07
0.12
0.15
0.32
0.18
0.51
0.05
0.25
0.08
0.26
0.03
0.12
0.06
0.13
0.05
0.17
Coefficient
of variation
[%]
6.3
4.0
5.0
4.0
5.1
4.5
2.9
3.7
5.8
6.8
4.3
5.6
5.2
4.9
4.8
.6.9
Sensitivity
The sensitivity of the methodlrexgressed as 3 X SD, ob-
tained by using the SD values determined at concentre
tion levels below 1 mg/24 h. The smallest amounts
differing significantly from zero are given for the indi-
vidual steroids in table 3.
Tab. 3. Standard deviations (S. D.) and smallest amounts
differing significantly from zero (3 X S. D.) for pregnan-
ediol and individual 17-oxo-steroids.
Standard deviations were determined at concentration
levels below 1 mg/24 h.
Steroid
Pregnanediol
Androsterone
Etiocholanolone
Dehydroepiandrosterone
1 1 -Oxoandrosterone
1 1-Oxoetiocholanolone
1 10-Hydroxyandrosterone
1 Ij3-Hydroxyetiocho|anolone
Number
of
deter-
mination
23
7
3
11
12
22
30
19
S.D.
i/unol/
24 h]
0.07
0.15
0.09
0.02
0.11
0.08
0.12
0.13
Smallest
amount differ-
ing significant-
ly from zero
[μιηοΙ/24 h]
0.21
0.45
0.27
0.06
0,33
0.24
0.36
0.39
J, Clin. Chem. Clin. Biochem. / Vol. 15,1977 / No. 4
Külpmann and Breuer: Simultaneous determination of individual 17-oxosteroids and of prcgnanediol 229
Practicability
One technician can perform 20 analyses in one working
week (5 days). Since the method involves various chro-
matography, some skill and experience are required. The
method has been in use for three years in our laboratory.
Drug interference
The method described here is less susceptible to drug
interference as compared with methods which are based
on the determination of 17-oxosteroids by the Zimmer-
mann reaction (cf. 2—4). However, it should be stressed
that a number of compounds, particularly synthetic
steroids, may directly or indirectly interfere with the
determination and thereby falsify the result.
Discussion
Since no manageable methods are available for the direct
measurement of the glucuronides of 17-oxosteroids,
these compounds must be hydrolysed, a process which
implies certain problems. Thus, the formation of arte-
facts can only be avoided if enzymes are used for hydro-
lysis instead of hot mineral acids. To ensure complete
enzymatic hydrolysis of steroid conjugates, it is essen-
tial to remove all materials, present in the urine sample,
which may inhibit the enzymatic reactions. An efficient
way for the removal of interfering substances (e. g.
glucuronolactone) is the adsorption chromatography
of the urine on Ainberlite XAD-2 according to Bradlow
(13); simultaneously, this step leads to a reduction of
the volume of the urine sample which facilitates further
handling. Even under the mild conditions of enzymatic
hydrolysis, some artefacts may arise, whose formation
can be successfully prevented by the addition of anti-
biotics and traces of chloroform to the urine sample
(10). The suggestion of using chromatography on
XAD-2 to purify the urine before hydrolysis of the steroid
conjugates was made'in 1974 (16); since then, the advan-
tages of this procedure have been recognised (18). In
contrast to enzyme preparations of different origin,
solvolysis leads to a complete cleavage of steroid sul-
phates as was found with dehydroepiandrosterone sul-
phate as test compound. Using the well-known method
ofBurstein &Lieberman (14), no formation of artefacts
during solvolysis was noted; this agrees with reports by
other authors (11,19, 20,21). The use of internal radio-
active standards allows the calculation of 100% recovery.
The rates of recovery are almost identical for both
[7a-3H]dehydroepiandrosterone glücüronide and
[4-14C]dehydroepiandrosterone sulphate; as these two
conjugates are not easily accessible and fairly expensive,
it is recommended that [7a-3U]dehydroepiandrosterone
sulphate be used as an alternative internal standard.
The application of a special two-dimensional thin-layer
chromatography leads to a concentration of the 17-oxo-
steroid and pregnanediol fraction which means that only
tiny spots have to be eluted from the thin-layer plates.
This reduces the amount of nonspecific material which
may otherwise interfere with the gas Chromatographie
determination. The technique of two-dimensional thin-
layer chromatography allows the application of the
sample as a line, resulting in an improved resolution.
The stationary phase for gas-liquid chromatography
(OV 210/OV 225, 1:1.8), as described in the present
paper, permits the complete resolution of the individual
steroids within 15 min at a constant temperature. This
is a major advantage; compared with the temperature
programming of the column oven, isothermal gas-liquid
chromatography reduces the time for analysis, increases
the reproducibility and facilitates mechanization. More-
over, the phase OV 210/OV 225 is superior to the phase
XE-60 because of its higher thermal stability. Typical gas
chromatograms are shown in figures 1 a—1 c.
The special feature of the present method is the simul-
taneous and highly specific determination of seven 17-
oxosteroids and pregnanediol. The specificity is based
(1) on the chromatography of the urine on Amberlite
XAD-2, (2) on the two-dimensional thin-layer chroma-
tography and (3) on the gas chromatography of the
MSTFA derivatives of the steroids. For each individual
steroid, the specificity as well as the accuracy of its
determination were proven by mass fragmentography
(16,17).
The normal urinary excretion of 17-oxosteroids varies
with age, rising slowly from birth to puberty and then
rapidly to a maximum in the mid-twenties (males:
8-26 mg/24 h, mean 15 mg/24 h; females: 4-17 mg/
24 h, mean 10 mg/24 h) (22). Excretion in both sexes
declines during senescence. Although the average for
males is higher than that of females of comparable age,
the scatter is quite large, and there is considerable over-
lap of values. The daily excretion of 17-oxosteroids in
the young adult varies marginally from day to day. Of
the total, 70—85% is found in the glucuronide fraction,
which contains measurable amounts of all compounds
except dehydroepiandrosterone. The remainder of the
urinary 17-oxosteroids (15-30%) appear in the sulphate
fraction, of which dehydroepiandrosterone is frequently
the major component. Representative values for the
individual 17-oxosteroids and pregnanediol are shown
in table 4. The total amount of 17-oxosteroids excreted
in urine per 24 h does not depend on the intake of
fluid (23).
The simultaneous determination of individual 17-oxo-
steroids and pregnanediol is of great value in the dia-
gnosis of the adreno-genital syndrome and in the differen-
tiation of the various forms of enzyme deficiency,
underlying this disease. In patients with a 30-hydroxy-
steroid-oxidoreductase deficiency, the excretion of
dehydroepiandrosterone is elevated, whereas that of the
other 17-oxosteroids and of pregnanediol drops to un-
detectable values. In 11/3-hydroxylase deficiency, the
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Fig. 1. Gas chromatograms
a) of the trimethylsilylethers of the individual 17-oxosteroids and of pregnanediol. Each peak represents 400 ng of the pure
steroid,
b) of the fraction obtained from the urine (10 ml) of a male subject (30 years) after silylation,
c) of the fraction obtained from the urine (10 ml) of a female subject (11 years) suffering from a blastema of the adrenal cortex
after silylation.
Experimental conditions: 3% OV-210/3% OV-225 on Chromosorb WHP 100-120 mesh (1,0:1,8, vol/vol); column temperature:
235 °C, inlet temperature: 250 °C, detector temperature: 275 °C. - The gas chromatograms and b were recorded at the same
sensitivity, c at reduced sensitivity (one tenth of a).
Tab. 4. Urinary excretion of individual 17-oxosteroids and pregnanediol in normal subjects and in a girl (11 years) with an adrenal
cortex bias to m a before and after operation. ~\_—^
P: Pregnanediol; A: AndrosteronejE: Etiocholanolone; D: Dehydroepiandrosterone; OA: 11-Oxoandrosterone; OE: 11-Oxo-
etiocholanolone; HOA: 110-Hydroxyandrosterone;HOE: ll^Hydroxyetiocholanolone.
Opv
Female
Male
Male
Female
prae op.
Female
post. op.
Age
fV<»arc\
23
25
40
11
11
Amounts [μπιοΙ/24 h]
P
3.38
1.13
1.25
5.3
1.3
A
7.76
7.34
10.41
44.1
2.1
E
8.62
4.07
8.52
23.1
1.7
D
7.92
4.06
4.34
247.9
2.8
A
1.94
1.45
0.82
-
—
OE
2.99
—
0.66
^
—
HOA
3.20
2.42
2.26
23.5
1.3
HOE
3.40
-^
1.14
-
-
excretion of the 11-oxygenated 17-oxosteroids is
markedly decreased and that of the 11-deoxy-17-
oxosteroids as well as of pregnanediol increased. In
21-hydroxylase deficiency, the excretion of 17-qxp-
steroids is significantly elevated.
The diagnosis of carcinoma of the adrenal cortex is
facilitated by the determination of individual 17-oxo-
steroids; here, an unusual high excretion of dehydro-
epiandrosterone is regularly observed.
Furthermore, the differential determination of 17-oxo-
steroids may be useful in the evaluation of (a) hypo-
thalamic-hypophyseal disorders, such as dystrophia
adiposo^genitalis (Fr hlich** syndrome), anorexia
nervosa and hypopituitarism, and (b) gonadal disorders,
such as Stein-Leventhal syndrome and arfhenoblastoma.
There can be no doubt that the determination of indi-
vidual 17-oxosteroids will contribute to the elucidation
of many endocrinological disorders which are at present
poorly understood.
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